Tempest Therapeutics Inc. (TPST)
0.78
-0.03 (-3.63%)
At close: Mar 03, 2025, 3:59 PM
0.80
2.56%
After-hours: Mar 03, 2025, 04:47 PM EST
Tempest Therapeutics Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -29.49M | -35.71M | -28.3M | -19.21M | -44.57M | -27.19M | -84.58M | -82.26M | -73.22M | -49.52M | -29.04M | -13.51M |
| Depreciation & Amortization | 381K | 638K | 374K | 339K | 1.05M | 32K | 28K | 2.24M | 1.29M | 450K | 231K | 93K |
| Stock-Based Compensation | 2.55M | 1.56M | 1.1M | 453K | 310K | 1.43M | 6.89M | 9.21M | 19.34M | 12.41M | 5.09M | 1.38M |
| Other Working Capital | -2.41M | 867K | -404K | -497K | -1.58M | 716K | -392K | 5.75M | -361K | 10.08M | 10.14M | -599K |
| Other Non-Cash Items | 1.88M | 1.57M | 1.48M | 470K | 6.92M | 2.22M | 67.56M | 19.36M | 24.92M | -6.33M | -3.8M | 879K |
| Deferred Income Tax | n/a | n/a | n/a | n/a | -2.57M | n/a | n/a | n/a | n/a | n/a | n/a | -599K |
| Change in Working Capital | -2.68M | 868K | -613K | -1.07M | -2.05M | 1.04M | -1.84M | 4.58M | -532K | 12.4M | 9.42M | 599K |
| Operating Cash Flow | -27.36M | -31.07M | -25.96M | -19.02M | -41.22M | -23.65M | -20.34M | -61.73M | -50.29M | -30.59M | -18.09M | -11.16M |
| Capital Expenditures | -170K | -562K | -135K | -50K | -397K | -36K | -4K | -2.59M | -5.23M | -2.8M | -719K | -849K |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | -1.33M | 462K | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | -68.86M | -84.42M | -96.72M | -57.6M | -15.97M | -16.7M |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | 4.38M | 2.49M | 87.79M | 95.1M | 64.34M | 29.23M | 5.67M | n/a |
| Other Investing Acitivies | n/a | n/a | 38K | 44K | n/a | 476K | -1.45M | -1.55M | -681K | -1.61M | 5K | -93K |
| Investing Cash Flow | -170K | -562K | -97K | -6K | 3.99M | 1.12M | 458K | 8.1M | -38.29M | -32.79M | -11.02M | -17.64M |
| Debt Repayment | n/a | -4.74M | 15M | n/a | -202K | 6.48M | -4.46M | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | n/a | 7.28M | 10.64M | 34.6M | 27.14M | 33.32M | n/a | n/a | n/a | n/a | n/a | n/a |
| Financial Cash Flow | 35.6M | 11.4M | 59.06M | 34.6M | 26.94M | 78.55M | -4.46M | 54.15M | 125.39M | 51.71M | 32.41M | 39.03M |
| Net Cash Flow | 8.07M | -20.23M | 33.01M | 15.58M | -9.82M | 55.71M | -26.31M | 706K | 37.01M | -11.66M | 3.3M | 10.23M |
| Free Cash Flow | -27.53M | -31.63M | -26.09M | -19.07M | -41.62M | -23.68M | -20.34M | -64.32M | -55.52M | -33.39M | -18.81M | -12.01M |